| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Buprenorphine | FAERS: 3 | US FAERS | |
| 2 | Diovan Hct | FAERS: 1 | US FAERS | |
| 3 | Everolimus | FAERS: 1 | US FAERS | |
| 4 | Mesalamine | FAERS: 1 | US FAERS | |
| 5 | Omeprazole | FAERS: 1 | US FAERS | |
| 6 | Perindopril | FAERS: 1 | US FAERS | |
| 7 | gadodiamide | FAERS: 1 | US FAERS | |
| 8 | Albendazole | OFFSIDES | ||
| 9 | Alprostadil | OFFSIDES | ||
| 10 | Atracurium | OFFSIDES | ||
| 11 | Calcium Carbonate | OFFSIDES | ||
| 12 | Colchicine | OFFSIDES | ||
| 13 | Fluticasone-Salmeterol Drug Combination | OFFSIDES | ||
| 14 | Indapamide | OFFSIDES | ||
| 15 | Methimazole | OFFSIDES | ||
| 16 | Ribavirin | OFFSIDES | ||
| 17 | Valsartan | Canada Vigilance: 1 | Canada Vigilance | |
| 18 | carbidopa, levodopa drug combination | OFFSIDES | ||
| 19 | gadodiamide | OFFSIDES | ||
| 20 | urapidil | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.